Skip to main content

Security report for novartis.at

Novartis Österreich · Healthcare · Austria

Low risk. 3 critical or high findings in Security headers and SSL/TLS.

Security score

78/100

Risk levelLow

0–100, higher is better. How it is calculated

Novartis Österreich is the Austrian branch of the global healthcare leader Novartis AG, focusing on innovative pharmaceutical research and therapies. The website serves as an official portal providing information about their products, research, sustainability efforts, and career opportunities, targeting healthcare professionals, patients, and job seekers in Austria. The site is well-branded, professionally designed, and localized in German, reflecting the company's commitment to the Austrian market. Technically, the website is built on Drupal CMS and integrates modern analytics and marketing tools such as Google Tag Manager, Crazy Egg, and TikTok Pixel, with appropriate cookie consent mechanisms ensuring GDPR compliance. Security posture is strong with HTTPS enforced and no visible vulnerabilities or exposed sensitive data, although explicit security headers could be improved. The WHOIS data for the domain is unavailable, which limits domain registration trust analysis, but the strong brand presence and consistent content mitigate concerns. Overall, the website demonstrates a mature digital presence with good privacy and security practices, supporting Novartis's reputation as a trusted healthcare provider.

Scanned

NIS2 and GDPR posture

GDPR outside view
88/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

3 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…
  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1
    • High

      Weak SSL Key Length

      SSL certificate uses 256-bit key, which is considered weak

      What to do: Use at least 2048-bit RSA or 256-bit ECC key

      • CWE-326
      • OWASP A04:2025
      • Mozilla TLS: Mozilla Server Side TLS 6.0 intermediate: rsa_key_size 2048

Need hands-on remediation? Email guard@offseq.com

Keep watching novartis.at

This scan found 17 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
47
Security headers
65
Email security
85
DNS health
85
Network security
100
GDPR outside view
88
Average
78

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention novartis.at, from OffSeq Breach.

No leaked records found

Breach holds no records for novartis.at right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.

Monitor on Breach (opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Novartis Österreich operates as an essential entity within the healthcare sector, leveraging its parent company Novartis AG's global resources. The company maintains a strong market position through innovative therapies and a commitment to sustainability and social responsibility. The website reflects a business model centered on pharmaceutical research, patient engagement, and professional outreach. The presence of multiple localized sites and partner domains indicates a broad partnership ecosystem. The company's growth is supported by clear branding, comprehensive content, and active social media engagement. Revenue streams likely include pharmaceutical sales and healthcare services. The website's professional quality and GDPR compliance reinforce business credibility and customer trust.

Security posture

The website exhibits a solid security posture with mandatory HTTPS encryption and cookie consent mechanisms aligned with GDPR requirements. No critical vulnerabilities or exposed sensitive information were detected in the HTML content. The use of third-party analytics and marketing scripts is managed with user consent, reducing privacy risks. However, explicit security headers such as X-Frame-Options and X-Content-Type-Options are not visibly declared and should be implemented to enhance protection against clickjacking and MIME sniffing attacks. The absence of a public security policy or incident response contact limits transparency in security governance. Overall, the site is secure for users but could benefit from enhanced header configurations and published security policies.

Recommendations

  1. Implement and explicitly declare security headers including X-Frame-Options and X-Content-Type-Options to strengthen browser security.
  2. Publish a clear security policy and provide dedicated incident response contact information to improve transparency and trust.
  3. Regularly audit third-party scripts and tracking pixels to ensure they do not introduce vulnerabilities or privacy risks.
  4. Enhance WHOIS domain registration transparency if possible to improve domain trustworthiness and reduce ambiguity.
  5. Continue maintaining GDPR compliance with clear privacy and cookie policies and ensure ongoing user consent management.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Novartis Österreich
Description
Willkommen auf der offiziellen Website von Novartis Österreich. Als weltweit führendes Gesundheitsunternehmen mit Sitz in der Schweiz setzt sich Novartis dafür ein, das Leben der Menschen zu verbessern und zu verlängern. Unsere österreichische Niederlassung ist bestrebt, innovative Gesundheitslösungen anzubieten, um den sich wandelnden Bedürfnissen der Patienten gerecht zu werden.
Key services
Pharmaceutical research, Innovative therapies, Sustainability and social responsibility initiatives
Content quality
excellent
Branding
consistent

Technology

Stack
Drupal CMS, Google Tag Manager, Crazy Egg, TikTok Pixel
Frameworks
Bootstrap (implied by nav classes), Litepicker (date picker CSS variables)
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent banner
  • No exposed sensitive data in HTML
  • Secure forms with autocomplete off

Analytics and tracking

Services
Google Analytics (via GTM), Crazy Egg, TikTok Analytics
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Crazy Egg, TikTok Pixel
Marketing tools
Crazy Egg
Transparency
good

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content in German for Austria
  2. Strong branding consistent with Novartis global identity
  3. Multiple social media and official links present
  4. Cookie consent and privacy policy implemented with GDPR compliance
  5. No security or WAF blocking detected
  6. WHOIS data unavailable, limiting domain registration trust analysis
  7. Use of modern tracking and analytics tools with consent mechanisms
  8. No suspicious or malicious content detected
Technical notes

Notes

The website is built on Drupal CMS, leveraging modern web technologies and frameworks such as Bootstrap for responsive design and Litepicker for date selection UI elements. It integrates multiple analytics and marketing tools including Google Tag Manager, Crazy Egg, and TikTok Pixel, indicating a mature digital marketing strategy. The site is mobile-optimized with good accessibility features and SEO meta tags, including Open Graph and JSON-LD structured data for enhanced search engine and social media integration. Performance is moderate, with asynchronous loading of scripts to improve user experience. The technical infrastructure supports a professional and scalable web presence suitable for an enterprise healthcare organization.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with novartis.at. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review novartis.at.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.